Arxx Therapeutics
Biotechnology
View the employees at
Arxx Therapeutics-
View DetailsJonas Hallén Chief Medical Officer, Co-Founder at Arxx Therapeutics
-
View DetailsKari Grønås (prev. Dyvik) Board Member at Arxx Therapeutics-
Oslo, Oslo, Norway
-
View DetailsSigne Vedel Borchert Industrial PhD Candidate hos Arxx Therapeutics and Roskilde University-
Roskilde, Zealand, Denmark
-
Overview
Founded in 2018, Arxx Therapeutics develops a first-in-class monoclonal antibody with a unique mechanism of action targeting non-resolving tissue fibrosis
-
